Delivery Order SPE2DB20D7059-SPE2DB26FGRB4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Spikevax 2025-26 pediatric vaccine (6 months to 11 years old) in 0.25 mL syringes, valued at $6,512.80. This is a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this competitive award. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 pediatric vaccine (6 months to 11 years) in a 0.25 mL syringe formulation, with a ceiling value of $3,783.18. This firm fixed-price delivery order, awarded on October 24, 2025, with ultimate completion by November 17, 2025, carries no set-aside designation and represents a competitive award. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,953.84 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ML on September 26, 2025, with a completion date of September 29, 2025. This firm fixed price delivery order represents a pediatric vaccine supply for children ages 6 months to 11 years and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,605.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ml on October 29, 2025, with completion scheduled for November 20, 2025. This is a non-set-aside competitive award for pediatric COVID-19 vaccine delivery to support federal immunization programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.01 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) Syringe 0.25ML, a pediatric COVID-19 vaccine formulation. This firm fixed price delivery order, awarded on October 29, 2025, with an ultimate completion date of November 20, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,512.80 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Spikevax 2025-26 vaccine (6 months to 11 years) in 0.25 mL syringes. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 26, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $6,088.75 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25mL on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The product supplied—a pediatric COVID-19 vaccine formulation for children ages 6 months to 11...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes, valued at $7,227.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 20, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SPIKEVAX 2024-25 vaccine (12 years and up), 0.5ml syringes, with a ceiling value of $5,887.40. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5ML syringes, with a ceiling value of $1,177.48 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction reflecting the agency's procurement of influenza vaccines to support military healthcare operations. The order was placed under...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB26FGRB4Delivery Order
The Defense Logistics Agency awarded a Delivery Order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of SPIKEVAX 2025-26 pediatric vaccine (6 months to 11 years) in 0.25 milliliter syringes. Valued at $2,390.04 with firm fixed pricing, this non-set-aside competitive award is scheduled for completion by November 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfills this order as the place of performance location, leveraging its established role as a critical pharmaceutical distributor for federal medical procurement. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The pediatric vaccine delivery demonstrates the contractor's capability to supply specialized medical commodities across therapeutic domains in support of federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 10/29/25 |